MESOBLAST LTD- SPON ADR
MESO · NASDAQ
Updated at 2026-10-13 14:27:43
- Today's High
- $14.28
- Today’s Low
- $13.99
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $14.47
- Previous Close
- $14.27
- Volume
- 143.76K
- Market Cap
- $2.59B
- P/E Ratio
- --
- EPS
- $-0.04
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 55 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
- Country
- AU
- Listing Date
- 2004-12-16
- Fiscal Year End
- June
- Shares Outstanding
- 1.29B
- CIK
- 0001345099
- Website
- www.mesoblast.com
Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.
Financial Metrics
Revenue
2026-06-30
$34.99M
2026-03-31
$34.45M
2025-12-31
$25.67M
2025-09-30
$25.67M
Operating Expenses
2026-06-30
$40.07M
2026-03-31
$40.07M
2025-12-31
$37.35M
2025-09-30
$37.35M
Net Income
2026-06-30
-$8.66M
2026-03-31
-$8.66M
2025-12-31
-$20.08M
2025-09-30
-$20.08M
Net Profit Margin
2026-06-30
-24.77%
2026-03-31
-25.16%
2025-12-31
-78.22%
2025-09-30
-78.22%
Earnings Per Share
2026-06-30
--
2026-03-31
$0.00
2025-12-31
--
2025-09-30
$-0.07
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$9.32M
2026-03-31
-$9.32M
2025-12-31
-$12.53M
2025-09-30
-$12.53M
Effective Tax Rate
2026-06-30
-0.98%
2026-03-31
-0.97%
2025-12-31
-1.12%
2025-09-30
-1.12%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $34.99M | $34.45M | $25.67M | $25.67M |
| Operating Expenses | $40.07M | $40.07M | $37.35M | $37.35M |
| Net Income | -$8.66M | -$8.66M | -$20.08M | -$20.08M |
| Net Profit Margin | -24.77% | -25.16% | -78.22% | -78.22% |
| Earnings Per Share | -- | $0.00 | -- | $-0.07 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$9.32M | -$9.32M | -$12.53M | -$12.53M |
| Effective Tax Rate | -0.98% | -0.97% | -1.12% | -1.12% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.